Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hims & Hers Health, Inc. - SIC # 5041 -
Ticker
Exchange
SIC #
Website
Latest Ticker
HIMS
New York
5041
www.hims.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hims & Hers Health, Inc.
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?
- Jun 12th, 2026 9:30 am
The GLP-1 stock nobody is pricing in isn’t a drugmaker
- Jun 11th, 2026 7:30 am
Hims And Hers Expands Benefits As Investors Weigh Overvaluation And Volatility
- Jun 11th, 2026 12:12 am
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today
- Jun 10th, 2026 3:45 pm
OMCL vs. HIMS: Which Stock Is the Better Value Option?
- Jun 10th, 2026 9:40 am
Hims & Hers Health (HIMS) Up 15.8% Since Last Earnings Report: Can It Continue?
- Jun 10th, 2026 9:30 am
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
- Jun 8th, 2026 7:00 am
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?
- Jun 7th, 2026 8:52 am
Hims CMO Appointment Highlights Longevity Focus And Raises Valuation Questions
- Jun 5th, 2026 10:09 am
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant
- Jun 5th, 2026 6:53 am
HIMS Stock Slides Overnight: CEO Sees Healthcare Potential In Anthropic's AI Leap As Lilly, WeightWatchers Turn Up The Heat
- Jun 5th, 2026 1:29 am
1 Growth Stock Set to Flourishand 2 We Ignore
- Jun 4th, 2026 4:29 pm
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
- Jun 4th, 2026 7:00 am
HIMS Stock Eyes 2-Week Green Streak: Analyst Sees Nearly 20% Upside On Multi-Year Opportunity In Peptides
- Jun 4th, 2026 2:27 am
Taking A Fresh Look At Hims & Hers Health (HIMS) Valuation After Recent Share Price Swings
- Jun 3rd, 2026 6:13 am
Political Scrutiny Tests Hims And Hers GLP1 Weight Loss Growth Story
- Jun 3rd, 2026 5:11 am
HIMS Stock Slips Despite Early Eucalyptus Buyout Close: Analyst Sees 10% Downside On GLP-1 Profit Risks
- Jun 2nd, 2026 8:09 pm
Hims & Hers Expands With Eucalyptus Acquisition
- Jun 2nd, 2026 9:50 am
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Traders Assess AI Momentum
- Jun 2nd, 2026 7:05 am
2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds
- Jun 2nd, 2026 6:05 am
Scroll